Nasal spray adult patient actor portrayal meditating in a yoga class
Nasal spray adult patient actor portrayal meditating in a yoga class
Actor portrayal.
gradient
SPRAVATO®: proven effective for depressive
symptoms
in adults with major depressive disorder (MDD) with suicidal thoughts or actions (
MDSI
)

Limitations of Use:

SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.

It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.

It is not known if SPRAVATO® is safe and effective in children.

SPRAVATO® Nasal Spray Device
SPRAVATO® Nasal Spray Device
Nasal spray adult patient actor portrayal looking into the distance
Actor portrayal.

You may benefit from adding SPRAVATO® to your existing oral antidepressant.

In clinical studies of adults with MDD with suicidal thoughts or actions, those who took SPRAVATO® and an oral antidepressant experienced a greater reduction of depressive symptoms at 24 hours compared to those who received a placebo plus an oral antidepressant.*

*Based on an overall score on a standardized rating scale.

Nasal spray adult patient actor portrayal looking into the distance

You may benefit from adding SPRAVATO® to your existing oral antidepressant.

In clinical studies of adults with MDD with suicidal thoughts or actions, those who took SPRAVATO® and an oral antidepressant experienced a greater reduction of depressive symptoms at 24 hours compared to those who received a placebo plus an oral antidepressant.*

*Based on an overall score on a standardized rating scale.

Exclamation mark inside circle icon

If two or more antidepressants haven’t worked for you, you may have treatment-resistant depression (TRD). It’s time to talk to your doctor about a different treatment approach.

Further reductions were seen consistently through four weeks (25 days) of treatment, so it is important to follow the treatment plan that you and your healthcare provider have made. Not all patients will respond to SPRAVATO®.

SPRAVATO® Safety

SPRAVATO® Safety

Serious side effects of SPRAVATO® include feeling sleepy (sedation or loss of consciousness) feeling disconnected from yourself, your thoughts, feelings and things around you (dissociation); breathing problems (respiratory depression and respiratory arrest); abuse and misuse; increased risk of suicidal thoughts and behavior; increased blood pressure; problems with thinking clearly and bladder problems.

The most common side effects that can occur during and after taking SPRAVATO® include:

  • Dissociation
  • Dizziness
  • Nausea
  • Sedation
  • Spinning sensation
  • Numbness
  • Spinning sensation
  • Numbness
  • Feeling anxious
  • Lack of energy
  • Increased blood pressure
  • Vomiting
  • Feeling drunk
  • Feeling very happy or excited
  • Increased blood pressure
  • Vomiting
  • Feeling drunk
  • Feeling very happy or excited

If SPRAVATO® side effects occur, they usually happen right after taking SPRAVATO® and go away the same day

Less than 7% of patients stopped SPRAVATO® treatment due to side effects in short- and long-term clinical studies.

These are not all the possible side effects of SPRAVATO®. Please see the SPRAVATO® Medication Guide for the complete safety information.

To help ensure your safety, SPRAVATO® has a program called SPRAVATO® REMS (Risk Evaluation and Mitigation Strategy), which requires monitoring of safety

Because of the risks for sedation or loss of consciousness, dissociation, respiratory depression, and abuse and misuse, SPRAVATO® is only available through a restricted program called the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) Program. SPRAVATO® can only be administered at healthcare settings certified in the SPRAVATO® REMS Program. Patients treated in outpatient healthcare settings (e.g., medical offices and clinics) must be enrolled in the program.

REMS icon

Learn more about SPRAVATO® REMS

Person on top of a hand icon

There’s an increased risk of suicidal thoughts and behavior with SPRAVATO®

Call your healthcare provider right away if you have new or sudden changes in mood, behavior, thoughts or feelings, or if you develop suicidal thoughts or actions.

Phone icon

Help is available 24/7. If you’re struggling with suicidal thoughts, call 988 Suicide & Crisis Lifeline

English988 Suicide & Crisis Lifeline

Phone icon988

Español988 Línea de Vida de Suicidio y Crisis

Phone icon988

SPRAVATO® Dosing for MDSI

After you and your healthcare provider have decided SPRAVATO® is right for you and you understand the benefits and risks, you can start planning for treatment.

  • You’ll administer SPRAVATO® nasal spray yourself under the supervision of a healthcare provider in a certified SPRAVATO® treatment center
  • SPRAVATO® is taken twice a week for four weeks, along with an oral antidepressant
  • After four weeks, you and your healthcare provider will determine if continued treatment with SPRAVATO® is necessary
Twice weekly scheduling icon
Click here to learn about Instructions for Use

SPRAVATO® MDSI Patient Brochure

The SPRAVATO® Patient Brochure is a helpful resource to learn about SPRAVATO® and depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions (MDSI).

DownloadDownload icon

No footer links content fetched